BioNxt closes $2M private placement at $0.33 per unit

BioNxt Solutions Inc. (CSNX: BNXT)(OTCQB: BNXTF)(FSE: BXT) has closed a non-brokered private placement under the Listed Issuer Financing Exemption, issuing 6,060,606 units at $0.33 each for gross proceeds of approximately $2 million.

Each unit consists of one common share and one share purchase warrant. Each warrant allows the holder to purchase one additional share at $0.50 for 24 months from the closing date. The securities issued are not subject to a hold period under applicable Canadian securities laws.

The company paid $120,000 in cash finder's fees and issued 363,636 non-transferable finder's warrants to an arm's length finder, also exercisable at $0.50 per share for 24 months from issuance.

BioNxt said it intends to use the proceeds for European research and development operations, working capital, and general corporate purposes.

Separately, the company provided an update on its previously announced extension of unsecured convertible debentures, first disclosed on June 10, 2026. The extension process remains ongoing, with the company anticipating closing on or around July 10, 2026, subject to receipt of all necessary corporate approvals.

You May Also Be Interested In

• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Boeing wins $2 billion satellite contract from DoW
• GameStop drops Cohen’s $35B pay plan to focus on eBay acquisition